How much funding has Triomics raised?

Triomics has raised $52.0M in total funding, most recently a Series B round.

Who are Triomics's investors?

Triomics's investors include Lightspeed VP, General Catalyst, Battery Ventures, Nexus Venture Partners, Y Combinator Continuity Fund.

Where is Triomics headquartered?

Triomics is headquartered in San Francisco, California, United States.

What industry is Triomics in?

Triomics operates in Healthcare.

Triomics

Generative AI for Oncology EHRs

San Francisco, United States · Founded 2021 · $52.0M raised

Healthcare

YC W21

Headquarters: San Francisco, California
Employees: 11–50
Founded: 2021
Business Model: B2B

Website: triomics.com
Total Funding: $52.0M
Last Round: $22.0M Series BMay 2026
Rounds: 4

About

Triomics is helping cancer care providers by reducing the burden associated with manually reviewing patient charts. Utilizing our OncoLLM™—a family of oncology-focused language models—we are able to accelerate clinical trial enrollment, power quality improvement projects, and address many other key strategic priorities.

Summary

Triomics is a Healthcare company based in San Francisco, United States, founded in 2021. It has raised $52.0M in total across 4 rounds, most recently a $22.0M Series B round in May 2026. Investors include Lightspeed VP, General Catalyst and Battery Ventures.

LinkedIn X (Twitter)GitHub